Zealand Pharma issues almost USD 40m in shares

The firm’s issuance and private placement represent 6.6% of its currently registered share capital, and will bring in an expected total of DKK 275m (USD 39.4m).
Photo: Zealand Pharma / PR
Photo: Zealand Pharma / PR
by marketwire, translated by daniel pedersen

Biotech firm Zealand Pharma has announced a directed issuance of 2.89 million new shares and a private placement, corresponding to a total 6.6% of the firm’s share capital.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading